LXCHEM.NS(LXCHEM.NS)
LXCHEM.NS
No analyst ratings available
No analyst price targets available for LXCHEM.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $54.90B | $61.87B |
| Low | $49.05B | $50.68B |
| High | $60.76B | $73.06B |
| EBITDA Avg | $5.23B | $5.89B |
| Low | $4.67B | $4.83B |
| High | $5.79B | $6.96B |
| EBIT Avg | $3.61B | $4.07B |
| Low | $3.22B | $3.33B |
| High | $3.99B | $4.80B |
| Net Income Avg | $2.27B | $2.78B |
| Low | $1.95B | $1.87B |
| High | $2.58B | $3.70B |
| EPS Avg | $8.17 | $10.03 |
| Low | $7.03 | $6.74 |
| High | $9.30 | $13.33 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 2 |